Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2484-2025

ViziShot 2FLEX. Single Use Aspiration Needle. Recall

ViziShot 2FLEX. Single Use Aspiration Needle. Model Number: NA-U403SX-4019. The ViziShot 2 FLEX tissue biopsy device is made up of four main parts: a handle, a sheath, a needle, and a stylet. The sheath and needle are attached to the handle, and the stylet, which is removable, is located inside the needle tube.

FDA recall Class I

Ongoing

FDA lists this Class I recall for ViziShot 2FLEX. Single Use Aspiration Needle.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2484-2025
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Aug 6, 2025
FDA report date
Sep 17, 2025
Quantity in commerce
104,508 units
Distribution
See key details
FDA cause
Process design

What is being recalled?

ViziShot 2FLEX. Single Use Aspiration Needle. Model Number: NA-U403SX-4019. The ViziShot 2 FLEX tissue biopsy device is made up of four main parts: a handle, a sheath, a needle, and a stylet. The sheath and needle are attached to the handle, and the stylet, which is removable, is located inside the needle tube.

Affected model & UDI checker

Search the exact identifiers published for Z-2484-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
NA-U403SX-4019ViziShot 2FLEX. Single Use Aspiration Needle.Check source noticeNot specified
Not specifiedViziShot 2FLEX. Single Use Aspiration Needle.Check source notice00821925043060
FDA code information

Model Number: NA-U403SX-4019. UDI-DI: 00821925043060. Lot numbers: All lots manufactured after 7/29/2022.

View the original FDA recall notice

Why was this product recalled?

Potential for undetected, deformed a-traumatic tips.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Olympus Corporation of the Americas take?

Olympus notified consignees on about 08/06/2025 via letter. Consignees were instructed to examine inventory and quarantine any affected units, ensure all users of the device carefully read the content of this notification, including the reinforced text from the IFU and the product removal information, arrange for the return of affected units, and acknowledge receipt of the recall notification via the Olympus web portal. Consignees were also instructed to notify customers if the affected units were further distributed. ***Update 12/31/2025*** URGENT MEDICAL DEVICE RECALL letters were sent to additional customers on January 9, 2026 with identical instructions. ***Edit 3/23/26: January 9, 2026 letters users were instructed to return all affected devices.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology